202 related articles for article (PubMed ID: 24813877)
21. 4-Thiazolidinones: the advances continue….
Tripathi AC; Gupta SJ; Fatima GN; Sonar PK; Verma A; Saraf SK
Eur J Med Chem; 2014 Jan; 72():52-77. PubMed ID: 24355348
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives.
Georgey H; Abdel-Gawad N; Abbas S
Molecules; 2008; 13(10):2557-69. PubMed ID: 18927518
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and anticonvulsant activity of some sulfamides.
Gavernet L; Barrios IA; Cravero MS; Bruno-Blanch LE
Bioorg Med Chem; 2007 Aug; 15(16):5604-14. PubMed ID: 17544673
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 3-[(2,4-dioxo-1,3,8-triazaspiro[4.6]undec-3-yl)methyl]benzonitrile derivatives as potential anticonvulsants.
Madaiah M; Prashanth MK; Revanasiddappa HD; Veeresh B
Arch Pharm (Weinheim); 2013 Mar; 346(3):200-9. PubMed ID: 23335463
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and potential 6 Hz psychomotor seizure test activity of some novel 2-(substituted)-3-{[substituted]amino}quinazolin-4(3H)-one.
Kumar P; Shrivastava B; Pandeya SN; Stables JP
Eur J Med Chem; 2011 Apr; 46(4):1006-18. PubMed ID: 21306800
[TBL] [Abstract][Full Text] [Related]
26. CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.
Jatav V; Mishra P; Kashaw S; Stables JP
Eur J Med Chem; 2008 Sep; 43(9):1945-54. PubMed ID: 18222569
[TBL] [Abstract][Full Text] [Related]
27. New quinazolinones-4. Antiinflammatory and anticonvulsant agents. New classes of pharmacologically active compounds.
Nawrocka W; Staśko JJ
Boll Chim Farm; 1998 Feb; 137(2):35-9. PubMed ID: 9595833
[TBL] [Abstract][Full Text] [Related]
28. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticonvulsant properties of some novel quinazolinone thiazolidine and 4-thiazolidone derivatives.
el-Feky SA
Pharmazie; 1993 Dec; 48(12):894-6. PubMed ID: 8115435
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of 5-alkoxy-[1,2,4]triazolo[4,3-a]quinoline derivatives with anticonvulsant activity.
Guo LJ; Wei CX; Jia JH; Zhao LM; Quan ZS
Eur J Med Chem; 2009 Mar; 44(3):954-8. PubMed ID: 18752871
[TBL] [Abstract][Full Text] [Related]
31. Triazole incorporated thiazoles as a new class of anticonvulsants: design, synthesis and in vivo screening.
Siddiqui N; Ahsan W
Eur J Med Chem; 2010 Apr; 45(4):1536-43. PubMed ID: 20116140
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis of 8-alkoxy-5,6-dihydro-[1,2,4]triazino[4,3-a]quinolin-1-ones with anticonvulsant activity.
Sun XY; Zhang L; Wei CX; Piao HR; Quan ZS
Eur J Med Chem; 2009 Mar; 44(3):1265-70. PubMed ID: 18950901
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anticonvulsant activity of ethyl 1-(2-arylhydrazinecarboxamido)-2,2-dimethylcyclopropanecarboxylate derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Xiao Y; Hu X
Eur J Med Chem; 2012 Aug; 54():542-8. PubMed ID: 22727446
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anticonvulsant evaluation of 6-amino-1,4-oxazepane-3,5-dione derivatives.
Sharma G; Park JY; Park MS
Arch Pharm Res; 2008 Jul; 31(7):838-42. PubMed ID: 18704324
[TBL] [Abstract][Full Text] [Related]
35. Design & synthesis of 2-(substituted aryloxy)-5-(substituted benzylidene)-3-phenyl-2,5-dihydro-1H-[1,2,4] triazin-6-one as potential anticonvulsant agents.
Kaushik D; Khan SA; Chawla G
Eur J Med Chem; 2010 Sep; 45(9):3960-9. PubMed ID: 20573424
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticonvulsant activity of 4-(2-(2,6-dimethylphenylamino)-2-oxoethylamino)-N-(substituted)butanamides: a pharmacophoric hybrid approach.
Yogeeswari P; Sriram D; Sahitya P; Ragavendran JV; Ranganadh V
Bioorg Med Chem Lett; 2007 Jul; 17(13):3712-5. PubMed ID: 17481896
[TBL] [Abstract][Full Text] [Related]
38. Structural and molecular modeling studies of quinazolinone anticonvulsants.
Duke NE; Codding PW
Acta Crystallogr B; 1993 Aug; 49 ( Pt 4)():719-26. PubMed ID: 8397980
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives.
Pevarello P; Bonsignori A; Dostert P; Heidempergher F; Pinciroli V; Colombo M; McArthur RA; Salvati P; Post C; Fariello RG; Varasi M
J Med Chem; 1998 Feb; 41(4):579-90. PubMed ID: 9484507
[TBL] [Abstract][Full Text] [Related]
40. Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011-2016).
Hameed A; Al-Rashida M; Uroos M; Ali SA; Arshia ; Ishtiaq M; Khan KM
Expert Opin Ther Pat; 2018 Apr; 28(4):281-297. PubMed ID: 29368977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
